BlackRock Inc. - CNS PHARMACEUTICALS INC ownership

CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 23 filers reported holding CNS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$14,000
-51.7%
41,087
-1.7%
0.00%
Q4 2021$29,000
-51.7%
41,803
+2.7%
0.00%
Q3 2021$60,000
-26.8%
40,718
-2.1%
0.00%
Q2 2021$82,000
+645.5%
41,586
+670.5%
0.00%
Q1 2020$11,000
+450.0%
5,397
+835.4%
0.00%
Q4 2019$2,0005770.00%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 20,745$41,0000.00%
Integrated Advisors Network LLC 10,700$21,0000.00%
Alpha Cubed Investments, LLC 11,000$22,0000.00%
Renaissance Technologies 432,109$847,0000.00%
TWO SIGMA SECURITIES, LLC 11,061$22,0000.00%
Sterling Financial Planning, Inc. 600$1,0000.00%
UBS Group AG 4,676$9,0000.00%
Capital Analysts, LLC 1,000$2,0000.00%
OSAIC HOLDINGS, INC. 5,000$10,0000.00%
BANK OF AMERICA CORP /DE/ 2,000$4,0000.00%
View complete list of CNS PHARMACEUTICALS INC shareholders